HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sjögren-Larsson syndrome: phenotypic variability in two brothers with a neurocutaneous disorder.

Abstract
Sjögren-Larsson syndrome (SLS) is a rare autosomal recessively inherited neurocutaneous disorder caused by mutations in the ALDH3A2 gene that encodes fatty aldehyde dehydrogenase, an enzyme that catalyzes the oxidation of fatty aldehyde to fatty acid. It is characterized by an unusual combination of cutaneous and neurologic signs and symptoms. The authors describe two brothers of consanguineous parents with SLS, one of whom was born from a dizygotic twin pregnancy (with an apparently normal sister), and they focus on the variability of the clinical findings of the syndrome even among siblings and twins.
AuthorsLuciana Losito, Leonarda Gennaro, Marta De Rinaldis, Marilena Cacudi, Antonio Trabacca
JournalActa neurologica Belgica (Acta Neurol Belg) Vol. 112 Issue 2 Pg. 205-8 (Jun 2012) ISSN: 2240-2993 [Electronic] Italy
PMID22426667 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Aldehyde Oxidoreductases
  • long-chain-aldehyde dehydrogenase
Topics
  • Adolescent
  • Aldehyde Oxidoreductases (genetics)
  • Humans
  • Male
  • Neurocutaneous Syndromes (complications, genetics)
  • Phenotype
  • Sjogren-Larsson Syndrome (etiology)
  • Twins, Dizygotic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: